author-photo

Kellen L. Meadows

Duke University

19

Papers

397

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

A Phase I Trial of the IGF‐1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer

2018 Oncologist
Show All
- Source
- Cite
- Save
Citations (11)
Phase I study of pazopanib plus TH-302 in advanced solid tumors

2017 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (6)
Treatment of palmar-plantar erythrodysesthesia (PPE) with topical sildenafil: a pilot study

2015 Supportive Care in Cancer
Show All
- Source
- Cite
- Save
Citations (13)
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors

2014 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (4)
Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer

2014 Investigational New Drugs
Show All
- Source
- Cite
- Save
Citations (17)
Abstract C61: Phase I Study of pazopanib in combination with the investigational hypoxia-targeted drug TH-302.

2013 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)
Phase I Study of Bevacizumab, Everolimus, and Panobinostat (LBH-589) in Advanced Solid Tumors

2012 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (36)
Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors.

2012 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (3)
A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors

2012 Cancer Chemotherapy and Pharmacology
Show All
- Source
- Cite
- Save
Citations (35)
Anti-VEGF Therapies in the Clinic

2012 Cold Spring Harbor Perspectives in Medicine
- Kellen L. Meadows
- Herbert Hurwitz
Show All
- Source
- Cite
- Save
Citations (161)